PRAX: praxismedicines.com PEG multiplikatori
Epilepsiya dori vositalarining so'nggi bosqichdagi sinov natijalari kutilishi Praxis Precision Medicines (PRAX) uchun ijobiy fon yaratmoqda, tadqiqot va ishlanmalar (R&D) xarajatlari esa allaqachon narxga kiritilgan. Psixiatrik buzilishlar davolashning diversifikatsiyalashgan portfeli biznes risklarini yumshatadi. PEG adolatli qiymat tendentsiyasi ushbu muvozanatni tasdiqlaydi, bunda 0.00 qiymati yakuniy ko'rsatkichni ifodalaydi. Ion kanallari uchun innovatsion molekula kashf qilish platformasi markaziy nerv tizimi (CNS) terapiyasi sohasida yetakchilikni ta'minlaydi.
Praxis Precision Medicines (PRAX) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- balans bo'yicha xususiy kapital ma'lumotlari:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Umumiy qarzning kapitalga nisbati koeffitsiyenti Praxis Precision Medicines|PRAX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati praxismedicines.com|PRAX - Kompaniya qarzlari|Qarzlarning balans kapitallashuviga nisbati Praxis Medicines|PRAX - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli kredit va qarzlari Praxis Precision Medicines|Shoshilinch likvidlik praxismedicines.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
PRAX - Sof foyda|Kelajakdagi foyda Praxis Precision Medicines|PRAX - P/E multiplikatori|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Praxis Corp|PRAX - Narxning foydaga va o‘sish sur’atiga nisbati|Kompaniyaning to‘liq qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Praxis Medicines|PRAX - EBITDA operatsion foydasi|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda Praxis Precision Medicines|PRAX - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi praxismedicines.com|PRAX - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun foydaning prognoz qilingan o'sish sur'ati Praxis Precision Medicines
Kompaniyaning fundamental tahlili:Praxis Precision Medicines Inc - PRAX
PEG koeffitsiyenti biznesning bozor qiymatini uning foyda o'sishi bilan solishtirib, kapitalizatsiya joriy daromadlar kengayishi bilan asoslangan yoki yo'qligini aniqlaydi. Miya ion kanallari terapiyalarini ishlab chiqadigan Praxis Precision Medicines (PRAX) uchun PEG koeffitsiyenti tendentsiyasi kelgusidagi sug'urta to'lovlariga nisbatan baholashning adolatli ekanligini aks ettiradi va qiymatlar birdan past bo'lganda aktivning fundamental barqarorligini tasdiqlaydi.
Praxis Precision Medicines raqobatchilari
BIIB (Biogen Inc) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori NBIX (Neurocrine Biosciences Inc)|PEG multiplikatori Regencell Corp RGC|AXSM: Narx-foyda va o‘sish multiplikatori|ACAD (acadia-pharm.com) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|XENE: PEG multiplikatori|VKTX - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Supernus Pharma|Catalyst Corp (CPRX) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori DNLI (Denali Therapeutics)|HRMY (harmonybiosciences.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Biohaven BHVN|AMLX (Amylyx Pharmaceuticals Inc) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|TRVI - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti AVXL (Anavex Life Sciences Corp)|CBLL: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Prothena (PRTA)|ALEC (Alector Inc.) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Annexon Biosciences (ANNX)|PEG multiplikatori OMER|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Neurogene Therapeutics|Narxning foydaga va o‘sish sur’atiga nisbati AC Immune ACIU|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati voyagertherapeutics.com (VYGR)|Neumora Therapeutics, Inc. - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Scilex Holding SCLX|Tevogen Bio Holdings, Inc. (TVGN) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda Alpha Cognition Inc. (ACOG)|Narxning foydaga va o‘sish sur’atiga nisbati Cognition Therapeutics|O‘sishni hisobga olgan narx-foyda koeffitsiyenti IKT (inhibikase.com)|Narx-foyda va o‘sish multiplikatori SAVA (Cassava Sciences)|ASRT (assertiotx.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Coya Therapeutics COYA|VTGN - Narx-foyda va o‘sish multiplikatori|Ovid Rx - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda acumenpharm.com|CRVO: PEG multiplikatori|O‘sishni hisobga olgan narx-foyda koeffitsiyenti ATHE|CLNN (Clene Inc) - PEG multiplikatori|PepGen Corp (PEPG) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori JUNS|Narx-foyda va o‘sish multiplikatori relmada.com RLMD|PEG multiplikatori ANVS (Annovis Bio)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Grace Therapeutics Inc (GRCE)|AIFF - Narxning foydaga va o‘sish sur’atiga nisbati|KLTO (Klotho Neurosciences Inc) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|NRSN: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda revivapharma.com (RVPH)|Narxning foydaga va o‘sish sur’atiga nisbati MetaVia Inc.|NeurAxis Inc. (NRXS) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Helius Medical (HSDT)|PASG: Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Neuphoria Therapeutics NEUP|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti NERV|Athira Pharma - PEG multiplikatori|ADXN - PEG multiplikatori|ALZN (alzamend.com) - Narx-foyda va o‘sish multiplikatori|O‘sishni hisobga olgan narx-foyda koeffitsiyenti CYCN|Narxning foydaga va o‘sish sur’atiga nisbati Protagenic Therapeutics Inc.|O‘sishni hisobga olgan narx-foyda koeffitsiyenti KTTA (Pasithea)|PEG multiplikatori CRGT|ATXI - O‘sish sur’atiga tuzatilgan narx-foyda|Brainstorm Cell Therapeutics, Inc. - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori Cara Therapeutics Inc CARA|CHRO - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ELYM (Eliem Therapeutics)|intracellulartherapies.com (ITCI) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda Longboard Pharmaceuticals Inc (LBPH)|Narxning foydaga va o‘sish sur’atiga nisbati Marinus|NKGen Biotech Corp - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati NeuroBo Pharmaceuticals (NRBO)|SAGE (sagerx.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori SNPX (Synaptogenix)|PEG multiplikatori Trevena Inc. TRVN|VIGL: Narx-foyda va o‘sish multiplikatori|WENA (Anew Medical Inc.) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|CERE: PEG multiplikatori
